ECM
CTKB icon

ExodusPoint Capital Management’s Cytek Biosciences CTKB Stock Holding History

ExodusPoint Capital Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-62,970
Closed -$219K – 1644
2025
Q3 		$219K Sell
62,970
-171,727
-73% -$645K ﹤0.01% 1367
2025
Q2 		$798K Buy
+234,697
New +$782K 0.01% 1027
2025
Q1 		– Sell
-77,536
Closed -$503K – 1557
2024
Q4 		$503K Sell
77,536
-41,706
-35% -$248K 0.01% 1153
2024
Q3 		$661K Buy
119,242
+82,208
+222% +$466K 0.01% 1102
2024
Q2 		$207K Buy
+37,034
New +$222K ﹤0.01% 1387
2023
Q2 		– Sell
-119,770
Closed -$1.1M – 1919
2023
Q1 		$1.1M Buy
+119,770
New +$1.29M 0.01% 1109
2022
Q2 		– Sell
-27,049
Closed -$292K – 2017
2022
Q1 		$292K Buy
+27,049
New +$365K ﹤0.01% 1772

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return